Richard Aldrich, Director at PTC THERAPEUTICS, INC. (PTCT), sold 7,000 shares at $56.05 ($390K) on 2015-06-08, disclosed to the SEC on 2015-06-10.
Scheduled sale ($390k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.65 | 6,896 | $384K | 98.5% |
| 2 | $56.05 | 104 | $6K | 1.5% |
| Total | $55.66 avg | 7,000 | $390K | 100% |
| Filing → |
| CNCE | SELL | 2018-02-01 | $356K | — | Filing → |
| CNCE | SELL | 2018-01-29 | $434K | — | Filing → |
| CNCE | SELL | 2018-01-24 | $689K | — | Filing → |